Carbizol^®

Indication:
Carbimazole is indicated in the management of hyperthyroidism, thyrotoxicosis (including thyroid storm), and also for the preparation of patients for thyroidectomy. Carbimazole can also be used in combination with radio-active ablative therapy.

Dosage & Administration:
Adults: The initial dose: 20 – 60 mg, in 2-3 divided doses until the patient is euthyroid. Daily dosage should be divided.
Maintenance regimen: Dose is gradually reduced to maintain a euthyroid state. Final dosage is usually in the range of 5 – 15 mg/day which may be taken as a single daily dose.
Neonates & Children below 12 years: The usual initial dose is 250 mcg /Kg/day in divided doses Duration of treatment: 18 to 24 months

Preparation:
Carbizol^® Tablet: Each tablet contains Carbimazole BP 5 mg.
Carbizol^® 10 Tablet: Each tablet contains Carbimazole BP 10 mg